Alphabet's Q4 2023 13F: Big Bets on Cybersecurity, Biotech, and ARM

Ticker: GOOG · Form: 13F-HR · Filed: 2024-02-09T00:00:00.000Z

Sentiment: bullish

Topics: institutional-holdings, investment-strategy, portfolio-disclosure, tech-investments

Related Tickers: CRWD, DXCM, ARM, ALEC, AUTL

TL;DR

**Alphabet's Q4 13F shows major stakes in CrowdStrike, Dexcom, and ARM, signaling strategic tech and biotech bets.**

AI Summary

Alphabet Inc. (GOOGL) filed its 13F-HR on February 9, 2024, revealing its holdings as of December 31, 2023. The filing shows significant investments in various companies, including a substantial position in CrowdStrike Holdings Inc. Class A (CRWD) valued at $327,749,944, representing 1,283,683 shares. Alphabet also holds 3,681,885 shares of Dexcom Inc. (DXCM) valued at $456,885,110 and 1,960,784 shares of ARM Holdings PLC Sponsored ADR (ARM) valued at $147,343,114. This matters to investors as it provides transparency into Alphabet's strategic investments, indicating areas of interest and potential future growth sectors for the tech giant, which could indirectly impact its core business and stock performance.

Why It Matters

This filing offers a rare glimpse into Alphabet's investment strategy, revealing where the tech giant is deploying capital outside its core operations. Understanding these investments can signal future growth areas or strategic partnerships that could impact Alphabet's long-term value.

Risk Assessment

Risk Level: low — 13F filings are backward-looking and represent a snapshot of holdings, so they don't indicate current risk but rather past investment decisions.

Analyst Insight

Investors should monitor Alphabet's future 13F filings for continued or increased positions in these key sectors, as they could indicate strategic priorities and potential growth drivers for the company. Researching the performance of these specific holdings (CrowdStrike, Dexcom, ARM) could offer insights into Alphabet's broader investment acumen.

Key Numbers

$327,749,944 — Value of CrowdStrike Holdings Inc. Class A shares (Represents Alphabet's largest disclosed holding by value as of December 31, 2023.)
1,283,683 — Shares of CrowdStrike Holdings Inc. Class A (The number of shares Alphabet held in CrowdStrike as of December 31, 2023.)
$456,885,110 — Value of Dexcom Inc. shares (Represents a significant holding in the medical device sector as of December 31, 2023.)
3,681,885 — Shares of Dexcom Inc. (The number of shares Alphabet held in Dexcom as of December 31, 2023.)
$147,343,114 — Value of ARM Holdings PLC Sponsored ADR shares (Represents a substantial investment in the semiconductor intellectual property sector as of December 31, 2023.)
1,960,784 — Shares of ARM Holdings PLC Sponsored ADR (The number of shares Alphabet held in ARM as of December 31, 2023.)
20231231 — Conformed Period of Report (The date for which the reported holdings are accurate.)
20240209 — Filed As Of Date (The date the 13F-HR filing was submitted to the SEC.)

Key Players & Entities

Alphabet Inc. (company) — filer of the 13F-HR
Fabian Souza (person) — Vice President, Deputy Controller who signed the filing
CrowdStrike Holdings Inc. Class A (company) — a significant holding in Alphabet's portfolio
Dexcom Inc. (company) — a significant holding in Alphabet's portfolio
ARM Holdings PLC Sponsored ADR (company) — a significant holding in Alphabet's portfolio
GV Management Company, L.L.C. (company) — an investment manager associated with Alphabet
Google LLC (company) — an investment manager associated with Alphabet
CapitalG II LP (company) — an investment manager associated with Alphabet
Verily Life Sciences LLC (company) — an investment manager associated with Alphabet
CapitalG III LP (company) — an investment manager associated with Alphabet

Forward-Looking Statements

Alphabet will continue to increase its exposure to cybersecurity and biotech sectors. (Alphabet Inc.) — medium confidence, target: Q1 2024
The significant investment in ARM Holdings PLC suggests Alphabet's strategic interest in semiconductor design and intellectual property. (Alphabet Inc.) — high confidence, target: Next 12 months

FAQ

What was the total value of Alphabet Inc.'s investment in CrowdStrike Holdings Inc. Class A as of December 31, 2023?

As of December 31, 2023, Alphabet Inc.'s investment in CrowdStrike Holdings Inc. Class A was valued at $327,749,944, representing 1,283,683 shares.

Which company represented Alphabet Inc.'s largest holding by value in this 13F-HR filing?

Based on the provided information table, Dexcom Inc. (COM) was Alphabet Inc.'s largest holding by value at $456,885,110, comprising 3,681,885 shares.

Who signed the 13F-HR filing for Alphabet Inc. and what is their role?

The 13F-HR filing for Alphabet Inc. was signed by Fabian Souza, who holds the title of Vice President, Deputy Controller.

What was Alphabet Inc.'s investment in ARM Holdings PLC Sponsored ADR as of the reporting period?

As of December 31, 2023, Alphabet Inc. held 1,960,784 shares of ARM Holdings PLC Sponsored ADR, valued at $147,343,114.

Besides Alphabet Inc., which other entities are listed as investment managers in this filing?

The filing lists GV Management Company, L.L.C., Google LLC, CapitalG II LP, Verily Life Sciences LLC, and CapitalG III LP as other investment managers.

From the Filing

0001652044-24-000034.txt : 20240209 0001652044-24-000034.hdr.sgml : 20240209 20240208174656 ACCESSION NUMBER: 0001652044-24-000034 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240209 DATE AS OF CHANGE: 20240208 EFFECTIVENESS DATE: 20240209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alphabet Inc. CENTRAL INDEX KEY: 0001652044 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 611767919 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-22702 FILM NUMBER: 24610439 BUSINESS ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-253-0000 MAIL ADDRESS: STREET 1: 1600 AMPHITHEATRE PARKWAY CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 13F-HR 1 primary_doc.xml X0202 13F-HR LIVE false false false 0001652044 XXXXXXXX 12-31-2023 12-31-2023 false Alphabet Inc. 1600 Amphitheatre Parkway Mountain View CA 94043 13F HOLDINGS REPORT 028-22702 028-22702 N Fabian Souza Vice President, Deputy Controller 650-253-0000 /s/ Fabian Souza Mountain View CA 02-08-2024 5 48 2156716052 false 1 0001940173 028-22704 GV Management Company, L.L.C. 2 0001824723 028-22705 Google LLC 3 0001779076 028-22706 CapitalG II LP 4 0001848282 028-22703 Verily Life Sciences LLC 5 0001998562 CapitalG III LP INFORMATION TABLE 2 information_table.xml INFORMATION TABLE ALECTOR INC COM 014442107 1403410 175866 SH DFND 1 0 175866 0 ARM HOLDINGS PLC SPONSORED ADR 042068205 147343114 1960784 SH DFND 2 0 1960784 0 AUTOLUS THERAPEUTICS PLC SPON ADR 05280R100 4496807 698262 SH DFND 1 0 698262 0 BARINTHUS BIOTHERAPEUTICS PL ADS 91864C107 5585346 1513644 SH DFND 1 0 1513644 0 BEAM THERAPEUTICS INC COM 07373V105 8754060 321604 SH DFND 1 0 321604 0 BENSON HILL INC COMMON STOCK 082490103 2609886 15352271 SH DFND 1 0 15352271 0 CROWDSTRIKE HLDGS INC CL A 22788C105 327749944 1283683 SH DFND 5 0 1283683 0 CUE HEALTH INC COM 229790100 4320 27000 SH DFND 4 0 27000 0 DESKTOP METAL INC COM CL A 25058X105 8286547 11048730 SH DFND 1 0 11048730 0 DEXCOM INC COM 252131107 456885110 3681885 SH DFND 4 0 3681885 0 DIANTHUS THERAPEUTICS INC COM 252828108 2170448 208697 SH DFND 1 0 208697 0 EXACT SCIENCES CORP COM 30063P105 1716706 23205 SH DFND 4 0 23205 0 FOGHORN THERAPEUTICS INC COM 344174107 3230811 500901 SH DFND 1 0 500901 0 FRESHWORKS INC CLASS A COM 358054104 94796127 4035595 SH DFND 0 4035595 0 FULCRUM THERAPEUTICS INC COM 359616109 96269 14262 SH DFND 4 0 14262 0 GITLAB INC CLASS A COM 37637K108 166674763 2647312 SH DFND 1 0 2647312 0 HYPERFINE INC COM CL A 44916K106 1006566 898720 SH DFND 1 0 898720 0 ILLUMINA INC COM 452327109 7445162 53470 SH DFND 1 0 53470 0 INVITAE CORP COM 46185L103 148432 235606 SH DFND 4 0 235606 0 INVIVYD INC COM 00534A102 22382292 5680785 SH DFND 1 0 5680785 0 KRONOS BIO INC COM 50107A104 1797790 1438232 SH DFND 1 0 1438232 0 LYELL IMMUNOPHARMA INC COM 55083R104 11378342 5865125 SH DFND 1 0 5865125 0 MONDEE HOLDINGS INC CLASS A COM 465712107 50839 18420 SH DFND 1 0 18420 0 MONTE ROSA THERAPEUTICS INC COM 61225M102 8271684 1464015 SH DFND 1 0 1464015 0 NEUMORA THERAPEUTICS INC. COM 640979100 6900681 404732 SH DFND 1 0 404732 0 OSCAR HEALTH INC CL A 687793109 4410190 481988 SH DFND 1 0 481988 0 OSCAR HEALTH INC CL A 687793109 10495956 1147099 SH DFND 2 0 1147099 0 PLANET LABS PBC COM CL A 72703X106 78898323 31942641 SH DFND 2 0 31942641 0 PRIME MEDICINE INC COM 74168J101 105101732 11862498 SH DFND 1 0 11862498 0 QUINCE THERAPEUTICS INC COM 22053A107 198578 189122 SH DFND 4 0 189122 0 RANI THERAPEUTICS HLDGS INC COM CL A 753018100 1488993 448492 SH DFND 1 0 448492 0 RAPT THERAPEUTICS INC COM 75382E109 13425709 540270 SH DFND 1 0 540270 0 RELAY THERAPEUTICS INC COM 75943R102 17221544 1564173 SH DFND 1 0 1564173 0 RELAY THERAPEUTICS INC COM 75943R102 50426 4580 SH DFND 4 0 4580 0 REPLIGEN CORP COM 7